-
EP3849558
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3849558
| EP3849558 - THIOCARBAMATE DERIVATIVES AS A2A INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND COMBINATIONS WITH ANTICANCER AGENTS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 03.05.2024 Database last updated on 02.09.2024 | |
| Former | Grant of patent is intended Status updated on 06.03.2024 | ||
| Former | Examination is in progress Status updated on 12.12.2023 | ||
| Former | Grant of patent is intended Status updated on 04.09.2023 | ||
| Former | Examination is in progress Status updated on 17.07.2023 | ||
| Former | Grant of patent is intended Status updated on 27.02.2023 | ||
| Former | Examination is in progress Status updated on 14.02.2023 | ||
| Former | Grant of patent is intended Status updated on 04.10.2022 | ||
| Former | Examination is in progress Status updated on 08.04.2022 | ||
| Former | Request for examination was made Status updated on 18.06.2021 | ||
| Former | The international publication has been made Status updated on 21.03.2020 | ||
| Former | unknown Status updated on 01.10.2019 | Most recent event Tooltip | 07.06.2024 | Change - divisional application(s) | published on 10.07.2024 [2024/28] | Applicant(s) | For all designated states iTeos Belgium SA Rue des Frères Wright 29 6041 Gosselies / BE | [2024/23] |
| Former [2021/29] | For all designated states iTeos Belgium SA Rue des Frères Wright 29 6041 Gosselies / BE | Inventor(s) | 01 /
CROSIGNANI, Stefano Allée de la Cense du Colombier 27 1400 Nivelles / BE | 02 /
DICKINSON, Paul 6 Turnberry Close, Tytherington Macclesfield, Cheshire SK10 2TQ / GB | 03 /
DE MATAS, Marcel 3 Castlebrook Close Unsworth Bury, Lancashire BL9 8JE / GB | 04 /
HOUTHUYS, Erica Joke Katelijne Heleen 91 rue de la Houille 7850 Petit-Enghien / BE | 05 /
MARILLIER, Reece Gerrad Colline des Sources, 10 1325 Bonlez - Chaumont-Gistoux / BE | 06 /
MARTINOLI, Chiara Via dei Grimani 15 20144 Milan / IT | 07 /
DE HENAU, Olivier Avenue Emile Van Becelaere 24 bte11 1170 Watermaele-Boitsfort / BE | 08 /
DRIESSENS, Gregory Rue du Monument, 29 1340 Ottignies / BE | [2022/44] |
| Former [2021/29] | 01 /
CROSIGNANI, Stefano Allée de la Cense du Colombier 27 1400 Nivelles / BE | ||
| 02 /
DICKINSON, Paul 6 Turnberry Close, Tytherington Macclesfield, Cheshire SK10 2TQ / GB | |||
| 03 /
DE MATAS, Marcel 3 Castlebrook Close, Unsworth Bury Lancashire BL9 8JE / GB | |||
| 04 /
HOUTHUYS, Erica Joke Katelijne Heleen 91 rue de la Houille 7850 Petit-Enghien / BE | |||
| 05 /
MARILLIER, Reece Gerrad Colline des Sources, 10 1325 Bonlez - Chaumont-Gistoux / BE | |||
| 06 /
MARTINOLI, Chiara Via dei Grimani 15 20144 Milan / IT | |||
| 07 /
DE HENAU, Olivier Avenue Emile Van Becelaere 24 bte11 1170 Watermaele-Boitsfort / BE | |||
| 08 /
DRIESSENS, Gregory Rue du Monument, 29 1340 Ottignies / BE | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [2024/23] |
| Former [2021/29] | Icosa 83 avenue Denfert-Rochereau 75014 Paris / FR | Application number, filing date | 19772998.1 | 11.09.2019 | [2021/29] | WO2019EP74208 | Priority number, date | US201862729808P | 11.09.2018 Original published format: US 201862729808 P | BE20180000103 | 11.09.2018 Original published format: BE 201800103 | US201862737723P | 27.09.2018 Original published format: US 201862737723 P | BE20180000114 | 27.09.2018 Original published format: BE 201800114 | [2021/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020053263 | Date: | 19.03.2020 | Language: | EN | [2020/12] | Type: | A1 Application with search report | No.: | EP3849558 | Date: | 21.07.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.03.2020 takes the place of the publication of the European patent application. | [2021/29] | Type: | B1 Patent specification | No.: | EP3849558 | Date: | 05.06.2024 | Language: | EN | [2024/23] | Search report(s) | International search report - published on: | EP | 19.03.2020 | Classification | IPC: | A61K31/519, C07D497/14, A61K31/337, A61K31/513, A61K31/555, A61K31/704, A61K31/7068, A61K45/06, A61K47/10, A61K47/12, A61K47/14, A61K47/22, A61K9/20, A61K9/16, A61K9/48, A61P35/00 | [2021/29] | CPC: |
A61K33/243 (EP,US);
C07D513/14 (EP,KR);
A61K31/519 (EP,KR,US);
A61K31/337 (EP,KR);
A61K31/513 (EP,KR);
A61K31/5377 (EP,US);
A61K31/555 (EP,KR);
A61K31/704 (EP,KR,US);
A61K31/7068 (EP,KR);
A61K39/3955 (EP,US);
A61K45/06 (EP,KR);
A61K47/10 (KR);
A61K47/20 (KR);
A61K9/4825 (KR);
A61K9/4858 (EP,US);
A61K9/4866 (EP,US);
A61P35/00 (EP,KR,US);
C07K16/2803 (EP);
C07K16/2818 (EP);
C07K16/2827 (EP);
A61K2300/00 (KR);
C07K2317/76 (EP)
(-)
| C-Set: |
A61K31/337, A61K2300/00 (EP);
A61K31/513, A61K2300/00 (EP);
A61K31/519, A61K2300/00 (EP);
A61K31/555, A61K2300/00 (EP);
A61K31/704, A61K2300/00 (EP);
A61K31/7068, A61K2300/00 (EP); | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/29] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | THIOCARBAMATDERIVATE ALS A2A-INHIBITOREN, PHARMAZEUTISCHE ZUSAMMENSETZUNG DAVON UND KOMBINATIONEN MIT ANTIKREBSMITTELN | [2021/29] | English: | THIOCARBAMATE DERIVATIVES AS A2A INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND COMBINATIONS WITH ANTICANCER AGENTS | [2021/29] | French: | DÉRIVÉS DE THIOCARBAMATE EN TANT QU'INHIBITEURS D'A2A, COMPOSITION PHARMACEUTIQUE ASSOCIÉE ET COMBINAISONS AVEC DES AGENTS ANTICANCÉREUX | [2021/29] | Entry into regional phase | 31.03.2021 | National basic fee paid | 31.03.2021 | Designation fee(s) paid | 31.03.2021 | Examination fee paid | Examination procedure | 31.03.2021 | Examination requested [2021/29] | 31.03.2021 | Date on which the examining division has become responsible | 20.10.2021 | Amendment by applicant (claims and/or description) | 08.04.2022 | Despatch of a communication from the examining division (Time limit: M04) | 02.08.2022 | Reply to a communication from the examining division | 12.09.2023 | Communication of intention to grant the patent | 12.12.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 21.12.2023 | Despatch of a communication from the examining division (Time limit: M02) | 08.02.2024 | Reply to a communication from the examining division | 07.03.2024 | Communication of intention to grant the patent | 30.04.2024 | Fee for grant paid | 30.04.2024 | Fee for publishing/printing paid | 30.04.2024 | Receipt of the translation of the claim(s) | Divisional application(s) | EP24179691.1 | Fees paid | Renewal fee | 27.09.2021 | Renewal fee patent year 03 | 27.09.2022 | Renewal fee patent year 04 | 26.09.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2005239795 (NEUSTADT BERNARD R [US], et al); | [A]WO2012038980 (ADVINUS THERAPEUTICS LTD [IN], et al); | [A]WO2012135084 (MERCK SHARP & DOHME [US], et al); | [ADP]WO2018178338 (ITEOS THERAPEUTICS [BE]); | by applicant | WO2015173764 | WO2018160704 | WO2018178338 | WO2019023504 | US10329349 | WO2018EP58301 |